NCT00751049

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom

A 6-month, Randomized, Double-masked Comparison of PhXA41 With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension. A Multi-centre Study in the United Kingdom

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 294 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

Study PhXA41 for its non-inferiority compared with timolol in lowering intra-ocular pressure

Conditions

• Ocular Hypertension
• Open Angle Glaucoma

Interventions

Type	Name	Description
DRUG	timolol	One drop in the affected eye every morning from the morning bottle and one drop every evening from the evening bottle
DRUG	PhXA41	One drop in the affected eye every morning from the morning bottle and one drop every evening from the evening bottle.

Timeline

• Start date: 1992-12-01
• Primary completion: 1993-12-01
• Completion: 1993-12-01
• First posted: 2008-09-11
• Last updated: 2021-02-02

Locations

12 sites across 1 country: United Kingdom